WHICH FEMARELLE PRODUCT IS RIGHT FOR YOU?

The decline in oestrogen levels starting in women’s 40s, leads to a chronic hormonal imbalance affecting women from this stage onwards. This change dramatically impacts women’s quality of life, from the onset of ‘menopausal’ signs to the progression of post-menopausal signs.

Femarelle® is based on numerous studies that have been published, and offers you high assurance of swift efficacy and safety for the long-term and prolonged quality of life.

PRE MENOPAUSAL

Rejuvenate targets the
perimenopause stage -
women in their 40s
confronted with the
start of hormonal fluctuations.

Symptoms may include:
Hair thinning and hair loss
Mood swings
Trouble sleeping

content-img
MENOPAUSAL

Recharge targets the
menopausal woman - women
suffering from the classic
symptoms that come with
the end of menstruation.

Symptoms may include:
Hot flushes and night sweats
Loss of libido
Declining energy levels

content-img
POST MENOPAUSAL

Unstoppable targets the
post-menopausal stage - women
who want to promote their
bone and vaginal health and
maintain better quality of life
and healthy aging.

Symptoms may include:
Low bone density
Aching muscles and joints
Vaginal dryness

content-img

HOW FEMARELLE WORKS

The in-house-developed DT56a is at the core of each product in the line, targeting the oestrogen receptors while each product contains different vitamins and minerals, boosting the beneficial impact on the target tissue.​

DT56a, is a non-hormonal proprietary API, originating from the soybean plant, processing the 20 amino acids within the soybean, creating, a unique compound that has been modulated to form the desired effect within the woman’s body, by bonding to the oestrogen receptors without being recognised by the body as oestrogen, thus developing a non-hormonal botanical therapy that was declared in 2017 as the 1st line treatment for the management of menopause at the European Society of Gynaecology.

DT56a, a standardised compound with a clear fingerprint, mimics the structures that are recognised by oestrogen receptors in the woman’s body as oestrogen, bound together with either a co-activator or co-repressor, depending on the tissue forming a Selective oestrogen Receptor Modulator, having either an agonistic (activation) or antagonistic (blocking) effect on the oestrogen receptors.

Testimonials

Subscribe to our newsletter